Related Experiment Video
Updated: Feb 14, 2026
08:08
Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis
Published on: February 19, 2018
9.0K
[Relationship between immune response and secretory otitis media]
Summary
Otitis media with effusion (OME) involves fluid in the middle ear, causing hearing loss. Its exact causes and development are still being researched, with a focus on immune responses.
Area of Science:
- Otolaryngology
- Immunology
Context:
- Otitis media with effusion (OME) is characterized by middle ear fluid and conductive hearing loss.
- First described in 1867, the precise etiology and pathogenesis of OME remain unclear.
- OME can be associated with upper respiratory infections and head and neck cancer radiotherapy.
Purpose:
- To explore the current understanding of the causes and development of otitis media with effusion.
- To highlight the role of immune responses in OME research.
Summary:
- Eustachian tube dysfunction, middle ear infections, and allergic reactions are primary suspected causes of OME.
- Recent research increasingly focuses on the connection between immune responses and the development of otitis media with effusion.
Impact:
- Clarifying OME pathogenesis can lead to improved diagnostic and therapeutic strategies.
- Understanding the immune system's role may reveal novel treatment targets for OME.
Related Concept Videos
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
2
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
2
01:40Cell-mediated Immune Responses
84.3K
Overview
84.3K
01:36Humoral Immune Responses
84.2K
Overview
84.2K
01:03Dose-Response Relationship: Overview
5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
01:22Dose-Response Relationship: Potency and Efficacy
6.6K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.6K
01:25Dose-Response Relationship: Selectivity and Specificity
9.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.9K